This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Amp-Therapeutics Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Patricia Czihal: Innovator in Antibiotic Peptides
Introduction
Patricia Czihal is a prominent inventor based in Leipzig, Germany. She has made significant contributions to the field of medicine through her innovative work on antibiotic peptides. Her research focuses on developing novel solutions to combat microbial infections, which is a pressing issue in healthcare today.
Latest Patents
Patricia holds a patent for antibiotic peptides, which concerns novel antibiotic peptide and peptide derivatives, especially for use in medicine. This invention relates to compositions and methods for killing microbes, such as bacteria and fungi, and methods to treat microbial infections. The invention also includes a method for drug screening analysis. The peptides and peptide derivatives possess a specific general formula that enhances their effectiveness compared to naturally occurring apidaecin peptides. These advantages include increased half-life in mammalian serum, enhanced antimicrobial activity against human pathogens, a broader spectrum of antimicrobial activity, reduced resistance in microbes, and non-toxicity to human cells.
Career Highlights
Patricia Czihal is associated with Amp-Therapeutics GmbH, where she continues to advance her research in antibiotic peptides. Her work is crucial in the ongoing battle against antibiotic resistance and microbial infections.
Collaborations
Patricia collaborates with Ralf Hoffmann, contributing to the development of innovative solutions in the field of antibiotic research.
Conclusion
Patricia Czihal's contributions to antibiotic peptide research highlight her role as a key innovator in the medical field. Her work not only addresses critical health challenges but also paves the way for future advancements in antimicrobial therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile